Links

Tools

Export citation

Search in Google Scholar

Single Agent Anti-tumor Activity in Pd-1 Refractory Nsclc: Phase 1 Data from the First-in-human Trial of Nc318, a Siglec-15-targeted Antibody

Journal article published in 2019 by Jeffrey Weber ORCID
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Upload
Question mark in circle
Postprint: policy unknown
Upload
Question mark in circle
Published version: policy unknown
Upload